These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 25224784

  • 1. Effect of two-linked mutations of the FMO3 gene on itopride metabolism in Chinese healthy volunteers.
    Zhou LP, Tan ZR, Chen H, Guo D, Chen Y, Huang WH, Wang LS, Zhang GG.
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1333-8. PubMed ID: 25224784
    [Abstract] [Full Text] [Related]

  • 2. Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.
    Zhou W, Humphries H, Neuhoff S, Gardner I, Masson E, Al-Huniti N, Zhou D.
    Biopharm Drug Dispos; 2017 Sep; 38(6):389-393. PubMed ID: 28255999
    [Abstract] [Full Text] [Related]

  • 3. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate.
    Mushiroda T, Douya R, Takahara E, Nagata O.
    Drug Metab Dispos; 2000 Oct; 28(10):1231-7. PubMed ID: 10997945
    [Abstract] [Full Text] [Related]

  • 4. In vivo drug interactions of itopride and trimethylamine mediated by flavin-containing monooxygenase 3 in humanized-liver mice.
    Shimizu M, Uehara S, Suemizu H, Yamazaki H.
    Drug Metab Pharmacokinet; 2021 Apr; 37():100369. PubMed ID: 33513464
    [Abstract] [Full Text] [Related]

  • 5. Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects.
    Katagiri F, Shiga T, Inoue S, Sato Y, Itoh H, Takeyama M.
    Pharmacology; 2006 Apr; 77(3):115-21. PubMed ID: 16717477
    [Abstract] [Full Text] [Related]

  • 6. Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers.
    Tang YJ, Hu K, Huang WH, Wang CZ, Liu Z, Chen Y, Ouyang DS, Tan ZR, Zhou HH, Yuan CS.
    Biomed Res Int; 2017 Apr; 2017():4189678. PubMed ID: 28331852
    [Abstract] [Full Text] [Related]

  • 7. Bioavailability and tolerability of combination treatment with revaprazan 200 mg + itopride 150 mg: a randomized crossover study in healthy male Korean volunteers.
    Choi HY, Noh YH, Jin SJ, Kim YH, Kim MJ, Sung H, Jang SB, Lee SJ, Bae KS, Lim HS.
    Clin Ther; 2012 Sep; 34(9):1999-2010. PubMed ID: 22858177
    [Abstract] [Full Text] [Related]

  • 8. Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.
    Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, Yu KS, Jang IJ.
    Drug Des Devel Ther; 2014 Sep; 8():123-8. PubMed ID: 24470753
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and bioequivalence study of a fixed dose combination of rabeprazole and itopride in healthy Indian volunteers.
    Sahoo BK, Das A, Agarwal S, Bhaumik U, Bose A, Ghosh D, Roy B, Pal TK.
    Arzneimittelforschung; 2009 Sep; 59(9):451-4. PubMed ID: 19856792
    [Abstract] [Full Text] [Related]

  • 10. Comparative pharmacokinetic evaluation of extended release itopride HCl pellets with once daily tablet formulation in healthy human subjects: a two treatment, four period crossover study in fasted and fed condition.
    Nasiri MI, Yousuf RI, Shoaib MH, Siddiqui F, Qazi F, Ahmed K, Anwer S, Zaheer K.
    Drug Dev Ind Pharm; 2019 Mar; 45(3):415-422. PubMed ID: 30457018
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic and bioequivalence study of itopride HCl in healthy volunteers.
    Cho KJ, Cho W, Cha KH, Park J, Kim MS, Kim JS, Hwang SJ.
    Arzneimittelforschung; 2010 Mar; 60(3):137-40. PubMed ID: 20422945
    [Abstract] [Full Text] [Related]

  • 12. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.
    Shimizu M, Allerston CK, Shephard EA, Yamazaki H, Phillips IR.
    Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545
    [Abstract] [Full Text] [Related]

  • 13. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population.
    Park CS, Chung WG, Kang JH, Roh HK, Lee KH, Cha YN.
    Pharmacogenetics; 1999 Apr; 9(2):155-64. PubMed ID: 10376762
    [Abstract] [Full Text] [Related]

  • 14. Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients.
    Ren L, Teng M, Zhang T, Zhang X, Sun B, Qin S, Zhong L, Peng Z, Fan J.
    Pharmacogenomics; 2017 Feb; 18(3):265-275. PubMed ID: 28084894
    [Abstract] [Full Text] [Related]

  • 15. Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
    Yamada T, Mino Y, Naito T, Kawakami J.
    J Infect Chemother; 2019 Dec; 25(12):1019-1025. PubMed ID: 31239195
    [Abstract] [Full Text] [Related]

  • 16. Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.
    Shimizu M, Koibuchi N, Mizugaki A, Hishinuma E, Saito S, Hiratsuka M, Yamazaki H.
    Drug Metab Pharmacokinet; 2021 Jun; 38():100387. PubMed ID: 33831674
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of itopride in human serum by high-performance liquid chromatography with fluorescence detection and its application to a bioequivalence study.
    Singh SS, Jain M, Sharma K, Shah B, Vyas M, Thakkar P, Shah R, Singh S, Lohray B.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr 25; 818(2):213-20. PubMed ID: 15734161
    [Abstract] [Full Text] [Related]

  • 18. Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects.
    Van den Houte K, Carbone F, Pauwels A, Vos R, Vanuytsel T, Tack J.
    Neurogastroenterol Motil; 2019 Apr 25; 31(4):e13544. PubMed ID: 30706652
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients.
    Yamazaki H, Shimizu M.
    Curr Drug Metab; 2007 Jun 25; 8(5):487-91. PubMed ID: 17584019
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.